Company Filing History:
Years Active: 2006-2019
Title: Dan Gibson: Innovator in Cancer Therapy and Nucleic Acid Technologies
Introduction
Dan Gibson is a prominent inventor based in Jerusalem, Israel. He has made significant contributions to the fields of cancer therapy and nucleic acid technologies. With a total of 3 patents, his work focuses on improving drug performance and developing novel delivery agents for therapeutic applications.
Latest Patents
One of his latest patents involves Pt (IV) derivatives and nanocarriers comprising them. This invention provides Pt (IV) lipophilic derivatives aimed at enhancing drug performance in cancer therapy. Another notable patent features positively-charged peptide nucleic acid analogs with improved properties. This invention relates to novel types of peptide nucleic acids (PNAs) that include positively charged PNA units, which have an ethylene linker between the backbone and the nucleobase. These innovations have potential applications in antisense therapy and other therapeutic and diagnostic uses.
Career Highlights
Dan Gibson is associated with Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. His work at this esteemed institution has allowed him to explore groundbreaking research and development in his field.
Collaborations
Throughout his career, Dan has collaborated with notable colleagues such as Yechezkel Barenholz and Yousef Najajreh. These partnerships have further enriched his research and contributed to the advancement of innovative technologies.
Conclusion
Dan Gibson's contributions to cancer therapy and nucleic acid technologies highlight his role as a leading inventor in these fields. His innovative patents and collaborations continue to pave the way for advancements in medical science.